These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 29169295

  • 1. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
    Eisemann N, Waldmann A, Holleczek B, Katalinic A.
    J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
    [Abstract] [Full Text] [Related]

  • 2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A, Jöckel KH.
    Cancer; 2016 Feb 01; 122(3):432-7. PubMed ID: 26480048
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Melanoma mortality following skin cancer screening in Germany.
    Boniol M, Autier P, Gandini S.
    BMJ Open; 2015 Sep 15; 5(9):e008158. PubMed ID: 26373399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The many unanswered questions related to the German skin cancer screening programme.
    Stang A, Garbe C, Autier P, Jöckel KH.
    Eur J Cancer; 2016 Sep 15; 64():83-8. PubMed ID: 27371911
    [Abstract] [Full Text] [Related]

  • 11. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
    Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E.
    Cancer; 2012 Nov 01; 118(21):5395-402. PubMed ID: 22517033
    [Abstract] [Full Text] [Related]

  • 12. [Skin cancer screening in Germany: review after ten years].
    Hübner J, Eisemann N, Brunßen A, Katalinic A.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec 01; 61(12):1536-1543. PubMed ID: 30411137
    [Abstract] [Full Text] [Related]

  • 13. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
    Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A.
    Br J Cancer; 2017 Jan 17; 116(2):253-259. PubMed ID: 27898656
    [Abstract] [Full Text] [Related]

  • 14. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.
    Brunssen A, Waldmann A, Eisemann N, Katalinic A.
    J Am Acad Dermatol; 2017 Jan 17; 76(1):129-139.e10. PubMed ID: 27707591
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
    Waldmann A, Nolte S, Geller AC, Katalinic A, Weinstock MA, Volkmer B, Greinert R, Breitbart EW.
    Arch Dermatol; 2012 Aug 17; 148(8):903-10. PubMed ID: 22911184
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.